PRINCETON, N.J. (December 9, 2013) Princeton University has started a mass vaccination of students to try to stop an outbreak of type B meningitis.
Shortly after the vaccinations began at noon Monday, scores of students were in line and some had received the dose, U.S. Centers for Disease Control and Prevention meningitis expert Thomas Clark said.
The vaccine for the B strain of the meningococcal bacteria is not yet licensed for general use in the United States, although it has been allowed in Canada, Australia and Europe.
The U.S. Food and Drug Administration approved its use at Princeton.
Seven university students and one student visitor have been infected since March.
None of the cases has been fatal.